Cross-fund · 5 holders
ESPR
ESPERION THERAPEUTICS INC NE
CUSIP 29664W105
5
Tracked holders
$113.1M
Aggregate value
36,037,608
Shares
5
Active funds
Funds holding ESPR
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $55.3M | — | +2,853,005 | +23.6% |
| BlackRock | Institutional | Q1 2026 | $48.9M | — | +170,226 | +1.0% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $4.6M | 0.01% | +1,689,372 | NEW |
| Citadel | Multi-Strategy | Q1 2026 | $2.6M | — | -568,593 | -37.5% |
| Millennium | Multi-Strategy | Q1 2026 | $1.7M | — | -3,327,929 | -84.6% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.